Literature DB >> 2016870

Adolescent smoking and drinking: are they "epidemics"?

D C Rowe1, J L Rodgers.   

Abstract

During adolescence, cumulative prevalences of ever using alcohol and ever smoking a cigarette increase systematically and dramatically. We applied a statistical theory of the transmission of epidemic infectious disease to model life-time prevalences of smoking and drinking. Alcohol use prevalences fit closely to a logistic curve used to model an epidemic process that assumed adolescents have random contacts with one another each year. An "adequate contact" will convert a nondrinker to drinking status if he/she is contacted; drinkers average .48 adequate contacts per year. Smoking prevalences were fit assuming both that the entire population was "at risk" and that some individuals were "immune": the mean contact parameter was .28 for smoking if no immune class was assumed and .77 if an immune class was assumed. Extensions of these epidemic process models could include individual differences in contact rates and transitions among several smoking or drinking statuses (e.g., non-user, experimenter, regular user and recovered user).

Entities:  

Mesh:

Year:  1991        PMID: 2016870     DOI: 10.15288/jsa.1991.52.110

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  4 in total

1.  A longitudinal perspective on adolescent substance abuse.

Authors:  Harith Swadi
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 4.785

2.  Alcohol abuse in adolescence: an update.

Authors:  H Swadi
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

3.  The impact of peer social networks on adolescent alcohol use initiation.

Authors:  Marlon P Mundt
Journal:  Acad Pediatr       Date:  2011-07-26       Impact factor: 3.107

4.  Co-use of alcohol and tobacco among ninth-graders in Louisiana.

Authors:  Carolyn C Johnson; Larry S Webber; Leann Myers; Neil W Boris; Gerald S Berenson
Journal:  Prev Chronic Dis       Date:  2009-06-15       Impact factor: 2.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.